Rye Yap
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rye Yap has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ben Arthur Marson
Department of Orthopaedics and Trauma, School of Medicine, University of Nottingham, Nottingham, UK
1 shared publication - Charlotte Lucy Durand
Paediatric Emergency Department, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
1 shared publication - Debashis Dass
Hand Unit, The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, UK
1 shared publication Ibrahim Roushdi
Hand Unit, The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, UK
1 shared publicationJefin Edakalathur
Hand Unit, The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, UK
1 shared publication- Joel Chilaka
Alder Hey Children’s NHS Foundation Trust
1 shared publication
Latest Publications
- 1 November 2026
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 108 (8) , 648-656
Outcome of ankle fractures in children: an updated systematic review and meta-analysis
Low-risk ankle fractures in children are commonly managed with immobilisation, using options such as supportive bandages, removable boots/braces or casted devices. The aim of this study was to review the literature to determine the optimal treatment for these fractures. A systematic review of randomised controlled trials (RCTs) was conducted in November 2024. Comprehensive searches of MEDLINE, Embase and Cochrane CENTRAL were performed. Studies recruiting children (0-18 years) with low-risk, stable or suspected occult ankle fractures managed non-operatively were included, comparing different immobilisation devices. Unscheduled returns to healthcare facilities, patient-reported outcomes, functional outcomes, and complication rates were assessed. Seven RCTs involving 503 children were included. Compared with casts, removable boots/braces significantly reduced unscheduled healthcare visits (risk ratio [RR] 0.26; 95% confidence interval [CI] 0.13 to 0.52; p = 0.0001), shortened return to normal activities (mean difference [MD] -6.83 days; 95% CI -11.20 to -2.96; p = 0.0031), and improved functional scores (standardised mean difference [SMD] -0.79; 95% CI -1.03 to -0.55; p < 0.00001). Patient and parent satisfaction was also higher with removable devices. Supportive bandaging reduced missed school days (MD -0.49; 95% CI -0.81 to -0.18; p = 0.002) and accelerated return to baseline activities (14.17 vs 20.19 days; p = 0.0002), although results showed high heterogeneity. No significant differences were found in pain, complications, emotional wellbeing or mobility between groups. Removable boots or braces offer a favourable alternative to cast immobilisation for low-risk paediatric ankle fractures. However, the necessity of rigid over soft immobilisation remains uncertain. A definitive RCT based on a core outcome set and cost-effective analyses is required to inform treatment recommendations.
- 1 November 2026
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 108 (8) , 648-656
Outcome of ankle fractures in children: an updated systematic review and meta-analysis
Low-risk ankle fractures in children are commonly managed with immobilisation, using options such as supportive bandages, removable boots/braces or casted devices. The aim of this study was to review the literature to determine the optimal treatment for these fractures. A systematic review of randomised controlled trials (RCTs) was conducted in November 2024. Comprehensive searches of MEDLINE, Embase and Cochrane CENTRAL were performed. Studies recruiting children (0-18 years) with low-risk, stable or suspected occult ankle fractures managed non-operatively were included, comparing different immobilisation devices. Unscheduled returns to healthcare facilities, patient-reported outcomes, functional outcomes, and complication rates were assessed. Seven RCTs involving 503 children were included. Compared with casts, removable boots/braces significantly reduced unscheduled healthcare visits (risk ratio [RR] 0.26; 95% confidence interval [CI] 0.13 to 0.52; p = 0.0001), shortened return to normal activities (mean difference [MD] -6.83 days; 95% CI -11.20 to -2.96; p = 0.0031), and improved functional scores (standardised mean difference [SMD] -0.79; 95% CI -1.03 to -0.55; p < 0.00001). Patient and parent satisfaction was also higher with removable devices. Supportive bandaging reduced missed school days (MD -0.49; 95% CI -0.81 to -0.18; p = 0.002) and accelerated return to baseline activities (14.17 vs 20.19 days; p = 0.0002), although results showed high heterogeneity. No significant differences were found in pain, complications, emotional wellbeing or mobility between groups. Removable boots or braces offer a favourable alternative to cast immobilisation for low-risk paediatric ankle fractures. However, the necessity of rigid over soft immobilisation remains uncertain. A definitive RCT based on a core outcome set and cost-effective analyses is required to inform treatment recommendations.
- 15 February 2026
- Published by SAGE Publications in Journal of Hand Surgery (European Volume)
- Vol. 51 (5) , 623-629
Short-to-medium-term outcomes of MAÏA® dual mobility CMC joint arthroplasty
Introduction: There is no consensus on the ideal surgical intervention for trapeziometacarpal joint arthritis. Although trapeziectomy has been the preferred procedure for several decades, trapeziometacarpal joint replacement has been gaining favour over several years owing to improvements in implant design. Dual mobility implants have been introduced to reduce the risk of dislocation associated with earlier single mobility versions. The aim of this study was to report the medium-term clinical outcomes of trapeziometacarpal joint replacement using the MAÏA ® dual mobility implant, from a single tertiary referral centre. Methods: This study included 106 patients with trapeziometacarpal joint osteoarthritis who received MAÏA ® dual mobility implants between 2017 and 2023. Patients were selected based on clinical and radiological criteria, with exclusions for inflammatory arthritis and STT joint involvement. Outcomes were assessed pre- and postoperatively using validated clinical scores, grip strength and radiographs at set intervals. Results: Patients were followed for an average of 53 months (IQR 20 to 58 months). The Brief Michigan score improved from 42 to 83, the pain score improved from 7 to 1, pinch strength improved from 2 to 4 kg and power grip improved from 14 to 22 kg. Two cups were revised owing to symptomatic loosening, while an additional two cups exhibited loosening but were not revised as both patients were asymptomatic. There were two intraoperative trapezium fractures. Survivorship of implants with maximum final follow-up of 6 years was 97% (IQR 20 to 58 months). Conclusions: The MAÏA ® dual mobility implant shows good improvement in pain, strength, mobility, and patient reported outcomes over the medium term, with no dislocations. Level of evidence: Therapeutic IV
- 15 February 2026
- Published by SAGE Publications in Journal of Hand Surgery (European Volume)
- Vol. 51 (5) , 623-629
Short-to-medium-term outcomes of MAÏA® dual mobility CMC joint arthroplasty
Introduction: There is no consensus on the ideal surgical intervention for trapeziometacarpal joint arthritis. Although trapeziectomy has been the preferred procedure for several decades, trapeziometacarpal joint replacement has been gaining favour over several years owing to improvements in implant design. Dual mobility implants have been introduced to reduce the risk of dislocation associated with earlier single mobility versions. The aim of this study was to report the medium-term clinical outcomes of trapeziometacarpal joint replacement using the MAÏA ® dual mobility implant, from a single tertiary referral centre. Methods: This study included 106 patients with trapeziometacarpal joint osteoarthritis who received MAÏA ® dual mobility implants between 2017 and 2023. Patients were selected based on clinical and radiological criteria, with exclusions for inflammatory arthritis and STT joint involvement. Outcomes were assessed pre- and postoperatively using validated clinical scores, grip strength and radiographs at set intervals. Results: Patients were followed for an average of 53 months (IQR 20 to 58 months). The Brief Michigan score improved from 42 to 83, the pain score improved from 7 to 1, pinch strength improved from 2 to 4 kg and power grip improved from 14 to 22 kg. Two cups were revised owing to symptomatic loosening, while an additional two cups exhibited loosening but were not revised as both patients were asymptomatic. There were two intraoperative trapezium fractures. Survivorship of implants with maximum final follow-up of 6 years was 97% (IQR 20 to 58 months). Conclusions: The MAÏA ® dual mobility implant shows good improvement in pain, strength, mobility, and patient reported outcomes over the medium term, with no dislocations. Level of evidence: Therapeutic IV